文献速递临床试验与 GCP基础与转化研究

光生物调节疗法对颞下颌关节紊乱及口面部/颈部颅骨疼痛姑息治疗的研究方案:随机对照临床试验

Photobiomodulation therapy on the palliative care of temporomandibular disorder and orofacial/cervical skull pain: study protocol for a randomized controlled clinical trial.
PubMed 文献 · Trials · 2019-04-06

该研究方案拟开展随机、三盲、安慰剂对照临床试验,纳入200名成年颞下颌关节紊乱患者,随机分为活性光生物调节疗法组与安慰剂组各100例,评价疼痛、下颌运动、生活质量和睡眠质量。研究旨在验证光生物调节疗法对颞下颌关节紊乱及口面部和颈部颅骨疼痛的姑息治疗是否有效。

要点

  • 光生物调节疗法是一种无创疗法,可能用于肌肉骨骼疾病的管理。
  • 研究采用随机、三盲、安慰剂对照设计,计划纳入200名成人患者。
  • 主要评价指标包括疼痛视觉模拟量表、下颌运动、口腔健康影响程度和睡眠质量。

核心结论

  • 本研究将验证光生物调节疗法是否能有效减轻颞下颌关节紊乱及口面部和颈部颅骨疼痛。
  • 光生物调节疗法可能成为肌肉骨骼疾病管理的一种选择,因其具有镇痛、抗炎和再生作用且无创。

研究设计与样本

  • 随机、三盲、安慰剂对照临床试验,计划纳入200名18岁以上成年参与者。
  • 参与者随机分为两组(每组100例):1组为活性光生物调节疗法,2组为安慰剂。
  • 参与者接受三次光生物调节疗法或安慰剂治疗,并采用颞下颌关节紊乱研究诊断标准(RDC)进行评估。
  • 研究在圣保罗大学牙科学院牙科激光特别实验室(LELO)开展。

主要发现

  • 记录疼痛水平(视觉模拟量表VAS)、下颌运动(尺和卡尺测量)、生活质量(口腔健康影响程度量表OHIP-14)和睡眠质量(Epworth量表)。

关键数值与推荐

  • 颞下颌关节紊乱影响全球5%至12%的人口。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Temporomandibular disorder (TMD) is the most common cause of orofacial and cervical skull pain and is considered to be a public health problem, affecting 5% to 12% of the world population. TMD is multifactorial and there are several types of treatment, with the conservative types being indicated more often as they are less aggressive and reversible. The main aim of these treatments is to relieve symptoms, reduce of pain, and restore orofacial and cervical skull functions. Photobiomodulation therapy (PBMT), a noninvasive therapy, is an option for the management of musculoskeletal disorders due to its analgesic, anti-inflammatory, and regenerative effects. METHODS: The aim of the proposed study is to verify whether PBMT is effective for use in palliative care of TMD and orofacial and cervical skull pain. A randomized, triple-blinded, placebo-controlled clinical trial is proposed. This study will involve 200 adult participants (over 18 years of age) who will be randomly divided into two groups (n = 100): Group 1, active treatment (PBMT); and Group 2, placebo. Participants will be subjected to three sessions of PBMT or placebo and will be evaluated using the research diagnostic criteria (RDC) for TMD. Pain level (measured by a visual analog scale (VAS)), mandibular movements (measured by ruler and caliper), quality of life (measured by the Oral Health Impact Profile (OHIP)-14), and quality of sleep (measured by the Epworth scale) will be recorded. This study is being conducted at the Special Laboratory of Lasers in Dentistry (LELO) of the School of Dentistry of the University of Sao Paulo (USP). DISCUSSION: This study will verify whether PBMT is effective in reducing TMD and orofacial and cervical skull pain. PBMT may be an option for the management of musculoskeletal disorders due to its analgesic, anti-inflammatory, and regenerative effects, in addition to being a noninvasive technique. TRIAL REGISTRATION: Registro Brasileiro de Ensaios Clínicos, RBR-9b6mnj . Registered on 27 March 2018. Trial registry name: Laser de baixa potência no cuidado paliativo da disfunção temporomandibular e dor crânio orofacial e cervical. Ethics committee: #1774930 approved on 14 October 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Carvalho FR, Barros RQ, Gonçalves AS, et al. Photobiomodulation therapy on the palliative care of temporomandibular disorder and orofacial/cervical skull pain: study protocol for a randomized controlled clinical trial. Trials. 2019. PMID: 30954086. doi:10.1186/s13063-019-3294-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。